Industry report · Life Science
The State of Life Science Business Development, 2026
Where new life science business comes from right now: who buys, who signs, what makes them take the call and what a qualified first meeting looks like. Then a 5-tool kit to put it to work at your company this month.
- 6account types worth calling first
- 4people who sign or shape the decision
- 5events that open the door
- 5working tools in the kit at the back
What this guide covers, counted from our life science talk track and industry page.
Executive summary Read this if nothing else
4 things to know about life science business development
Call first
Pharmaceutical manufacturing sites
GMP plants with controlled equipment, validated systems and quality agreements for every critical vendor. Site changes and audits drive purchases.
Who signs
Director of lab operations
Open with this: Ask how many service providers they manage today and where downtime has hurt them most.
Best reason to call
An inspection or audit finding
Observations on equipment, data or suppliers create corrective actions with deadlines, and outside help gets approved fast.
Why deals stall
Supplier qualification slows every new account
The SDR learns qualification and quality agreement requirements early, so your team prepares before the first meeting.
Sources: Abstrakt life science talk track and industry page.
Chapter 01 The market
Where new life science business comes from
In pharma, medical device and clinical lab sites, the buying decision for services and equipment is shaped by compliance as much as by price. We book meetings with the lab operations, quality and site leaders who have to defend every vendor in an audit, for companies that sell lab services, validation, equipment, cold chain, facility support and outsourced clinical or regulatory work.
Referrals and inbound rarely fill a life science calendar on their own. The companies that grow pick the accounts that fit, reach the person who signs, and call when something has changed at the account. That is the order of this guide, and the toolkit at the back turns each chapter into work you can start on Monday.
Chapter 02 The buyer
Who to call, and who signs
The right account, then the right person inside it. Here is where life science business comes from, and who decides.
The accounts worth calling first
- Pharmaceutical manufacturing sitesGMP plants with controlled equipment, validated systems and quality agreements for every critical vendor. Site changes and audits drive purchases.
- Medical device manufacturersDesign controls, production equipment, sterilization and testing all run under a quality system with supplier qualification.
- Clinical and diagnostic laboratoriesHospital, reference and independent labs need analyzers, service coverage, supplies and staff to keep turnaround times under control.
- Contract research organizationsCROs buy lab services, software, equipment and specialist support to deliver studies for their sponsors.
- Academic medical centers and research institutesCore facilities and research operations run large equipment fleets, with buying through central procurement and grants.
- Pharma and device sponsors running trialsClinical operations teams outsource monitoring, data management, sample logistics and regulatory work across many sites.
The people who sign
Director of lab operations
Signs forEquipment uptime, service contracts, supplies and the vendors that keep the lab running.
Open withAsk how many service providers they manage today and where downtime has hurt them most.
Quality assurance or validation manager
Signs forSupplier qualification, validation work and what the auditor sees in vendor files.
Open withAsk what the last inspection or audit raised about equipment, data integrity or suppliers.
Site head or operations director
Signs forBudget for the facility, capacity plans and approval on large service agreements.
Open withLead with capacity and audit readiness at their site, not with a product list.
Clinical operations or strategic sourcing lead
Signs forOutsourced partner selection, preferred vendor programs and contract terms.
Open withAsk when preferred vendor lists are reviewed and what it takes to be qualified.
Chapter 03 The timing
What opens the door
Most life science buyers are not shopping on the day you call. These are the changes that make them start.
- An inspection or audit findingObservations on equipment, data or suppliers create corrective actions with deadlines, and outside help gets approved fast.
- New lines, labs or site expansionsNew capacity means equipment, qualification and validation, and service contracts chosen in a short window.
- Mergers and site consolidationNew owners standardize vendors across sites, which opens accounts that were closed for years.
- Service contract and preferred vendor renewalsMulti-year agreements come up for review, and that is when a new provider can get qualified.
- A new trial or product launchSponsors bring on clinical, logistics and regulatory partners as programs start, and timelines force decisions.
Chapter 04 The friction
Why life science pipelines stall
Where life science pipelines lose momentum, and what changes when they are fixed.
The problemSupplier qualification slows every new account
What changesThe SDR learns qualification and quality agreement requirements early, so your team prepares before the first meeting.
The problemMany people touch every decision
What changesWe map lab, quality, site and sourcing contacts at each account and work each of them with the issue they own.
The problemGatekeepers and procurement portals
What changesDirect outreach to operations and quality leaders creates a sponsor inside the account before procurement gets involved.
The problemLong contract cycles
What changesNurture keeps your company in front of the account until the renewal, expansion or audit opens a real opportunity.
Chapter 05 The meeting
What a qualified life science meeting looks like
Every meeting we book for a life science client clears three checks before it reaches the calendar: the right company, the right contact and the right timing.
- Right company. An account that fits the work you want, such as pharmaceutical manufacturing sites.
- Right contact. Someone who signs or shapes the decision, such as the director of lab operations.
- Right timing. A stated need or a reason to talk now, such as an inspection or audit finding.
Every meeting is then graded on our 25-point 5 Star Scorecard before it reaches a client. Use the same test on your own calendar: if you could not answer each line above before the meeting, it was not qualified yet. More on what counts as a qualified appointment.
Part two Apply this
The Life Science toolkit
5 working tools built from the chapters above. Tick the boxes as you go (they stay ticked in this browser), copy the scripts into your CRM, or save the whole guide as a PDF and print this part as a worksheet.
- 01Account scorecardScore an account before anyone dials it.
- 02Discovery question bankThe questions that qualify a meeting.
- 03Trigger watchlistThe changes that make a buyer take the call.
- 04Follow-up cadenceWhat to send after the call, and what to skip.
- 0530-day action planFour weeks of steps you can start Monday.
Tool 01
Account scorecard
Before an account goes on the call list, check every line that fits. Call the accounts with the most ticks first, and leave the ones with none for later.
Tool 02
Discovery question bank
Ask fewer, better questions. Pick three or four for the call and save the rest for the meeting. Each one comes with the reason it earns its place.
Opening with each buyer
The first question for each person who signs or shapes the decision.
- Ask how many service providers they manage today and where downtime has hurt them most.Director of lab operations
- Ask what the last inspection or audit raised about equipment, data integrity or suppliers.Quality assurance or validation manager
- Lead with capacity and audit readiness at their site, not with a product list.Site head or operations director
- Ask when preferred vendor lists are reviewed and what it takes to be qualified.Clinical operations or strategic sourcing lead
Finding the timing
One question per trigger on the watchlist. A yes is your reason to meet now.
- An inspection or audit finding: is this happening at your company, or coming up this year?
- New lines, labs or site expansions: is this happening at your company, or coming up this year?
- Mergers and site consolidation: is this happening at your company, or coming up this year?
- Service contract and preferred vendor renewals: is this happening at your company, or coming up this year?
- A new trial or product launch: is this happening at your company, or coming up this year?
Any first meeting
Plain practice that works in every industry.
- How are you handling this today, and what would you change about it?The gap between today and what they want is the whole reason to meet.
- What happens if nothing changes this year?Tells you whether there is a cost to waiting, or only curiosity.
- Who else would need to agree before anything moves?Names the people who can stall the deal, while you can still invite them.
- When does the current contract or budget come up for review?Gives you the date to plan around, even when the answer today is no.
- What would make a first meeting worth your time?Lets the buyer set the agenda, which is the agenda they will show up for.
Tool 03
Trigger watchlist
Each of these changes gives a buyer a reason to take the call this month instead of next year. Tick the ones you will track, and set a news alert or CRM field for each so you hear about it first.
Tool 04
Follow-up cadence
Most deals are won or lost after the first meeting. Use these stages as your template: every touch carries a reason, and none of them is "just checking in".
After the first call
Send a short recap in the buyer's own words: the problem they named, who else is involved and the next step you agreed. Write it so they can forward it to the quality assurance or validation manager without editing.
Skip: A brochure attachment that never mentions what they told you.
Before the meeting
Confirm the time and the attendees the day before. Ask whether the quality assurance or validation manager should join the director of lab operations. Bring one example that matches their kind of account.
Skip: Showing up with a generic deck and no questions written down.
After the meeting
Send what you promised, when you promised it, with the next step and a date on it. If a proposal is next, confirm who reads it and when they decide.
Skip: Ending on "let me know if you have questions", which leaves the next move to them.
When the answer is "not now"
Ask when the current contract, budget or plan comes up for review. Put that date in your calendar and call before it, not after.
Skip: Checking in with nothing new to say. Every touch should carry a reason.
When a trigger fires
Watch for an inspection or audit finding, new lines, labs or site expansions and mergers and site consolidation. Any one of them is a reason to call back with something specific to that change.
Skip: Waiting for the buyer to remember you when the change happens.
Tool 05
30-day action plan
4 weeks, 16 steps, nothing you need to buy. Tick each one off as you finish it; your progress stays in this browser.
Week 1Pick the accounts
Week 2Build the talk track
Week 3Make the calls
Week 4Follow up and measure
Appendix If you want it done for you
How a life science program runs
Build the list
Pharma sites, device makers, labs, CROs and sponsors that fit your offer, sorted by site type, regulatory profile and size, with operations, quality and sourcing contacts named.
Run the outreach
A U.S.-based SDR team works phone, email and LinkedIn under your company name, leading with uptime, audit readiness and capacity.
Book qualified meetings
Every meeting is with the right company, the right contact and a timing reason such as an audit, an expansion, a merger or a renewal.
Nurture the rest
Accounts locked into current vendors stay in a follow-up cadence until the next review or site change.
Sources and notes
- Abstrakt life science talk track, target accounts, decision-makers, triggers and qualification standards, as published on our Life Science page.
- The toolkit's general advice (scorecard, core questions, follow-up stages and the 30-day plan) is sales practice, not data.
